Out-of-pocket costs decline for patients with diabetes

Out-of-pocket costs decline for patients with diabetes

(HealthDay)—During the past decade, out-of-pocket (OOP) costs have declined for individuals with diabetes, according to research published online March 25 in Diabetes Care.

Rui Li, Ph.D., of the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues used 2001 to 2011 data from the Medical Expenditure Panel Survey to assess trends in OOP for individuals aged 18 to 64 years with .

The researchers found that the proportion of individuals with diabetes who have high OOP costs dropped by 5 percentage points (P < 0.01). In 2011, 23 percent of individuals with diabetes had a high OOP burden. During the study period, significant changes occurred in the proportions of diabetes patients who were publicly insured (22 percent decrease) or uninsured (12 percent decrease). No significant changes in OOP costs occurred in with private insurance or middle-to-high incomes, but significant reductions were observed for those who were poor and near-poor (21 percent decrease) and low-income (13 percent decrease).

"The past decade has seen a narrowing of insurance coverage and income-related disparities in high OOP burden in people with diabetes, yet almost one-fourth of all people with diabetes still face a high OOP burden," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Plant science could aid Alzheimer's research

Sep 23, 2013

A finding by an international team of plant biologists could be important in research into Alzheimer's and other age-related diseases.The study is published this week in the prestigious journal Proceedings of ...

Recommended for you

New test helps diagnose type 1 diabetes

3 hours ago

(HealthDay)—The U.S. Food and Drug Administration has approved a new test that may help doctors diagnose type 1 diabetes, the most common form diagnosed in children and adolescents.

Single enzyme is necessary for development of diabetes

Aug 14, 2014

An enzyme called 12-LO promotes the obesity-induced oxidative stress in the pancreatic cells that leads to pre-diabetes, and diabetes. 12-LO's enzymatic action is the last step in the production of certain small molecules ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

freethinking
not rated yet Apr 25, 2014
Not now, under the Obama and the Democrats, Obamacare.... out of pocket expenses have dramatically INCREASED....

But you won't hear that from the Propaganda arm of Physorg or the rest of the Main Stream media.....